our partners

The following organisations and Industry representatives have all played an important role in the start of the MyBrainNet project. We are very grateful for the support and collaboration.

Brain, Mind And Pain Patient-Centred Innovation Grant​

The Brain, Mind and Pain ‘Patient-Centred Innovation Grant’ (BMP Grant) is an initiative of Pain Alliance Europe and Grünenthal to identify, stimulate and encourage patient-centric and scientifically robust innovation in the domain of chronic pain and neurological disorders, to stimulate research and access to innovative treatments, to promote prevention and self-management approaches, to decrease stigma, and to work together to improve quality of life for people living with these disabling conditions.

European Federation of Neurological Associations​

The European Federation of Neurological Associations [EFNA] is an umbrella group representing pan-European neurology patient groups. EFNA embraces the concept of Partnership for Progress – working at a high level with relevant stakeholders from the fields of policy, medical, scientific/research, industry, patient partners and other key opinion leaders.

Merz Therapeutics

At Merz Therapeutics (a business of Merz Pharmaceuticals GmbH), we seek to address the unique needs of people who suffer from movement disorders, neurological conditions, and other health conditions that severely impact patients’ quality of life. With our patient-centric approach, cutting-edge research and development efforts, highly-scientific medical affairs resources and dedicated commercial teams, we continue the advancement of new and individualized treatment standards.


Ipsen is a leading global biopharmaceutical company focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Diseases. Ipsen is one of the global leaders in the discovery, development, manufacture and commercialization of neurotoxins. Neuroscience is core to Ipsen’s specialty care business, with their long-term commitment to advancing neuroscience and toxins research evidenced by over 25 years of clinical experience. They are fully committed to improving people’s lives through safe and effective treatments, support and services in spasticity, movement disorders and specific indications in esthetic medicine.